Navigation Links
Onyx Pharmaceuticals Reports 2008 First Quarter Results
Date:5/6/2008

of March 31, 2008, the company had cash, cash equivalents, and short and long-term marketable securities of $456.6 million compared to $469.7 million at December 31, 2007. This decrease was primarily due to cash used in operations for the three months ended March 31, 2008.

Conference Call with Management Today

Onyx's management will host a teleconference and webcast to provide an update on Nexavar and discuss first quarter 2008 financial results. The event will begin at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) on May 6, 2008. Interested parties may access a live webcast of the presentation on our website at:

http://www.onyx-pharm.com/wt/page/event_calendar

or by dialing 630-691-2760 and using the passcode 21488196. A replay of the presentation will be available on the Onyx website or by dialing 630-652-3044 and using the passcode 21488196 approximately one hour after the teleconference concludes. The replay will be available through June 6, 2008.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer by changing the way cancer is treated(TM). The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R) (sorafenib) tablets, a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in non-small cell lung cancer, melanoma, breast cancer and other cancers. For more information about Onyx, visit the company's website at: http://www.onyx-pharm.com.

Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals Inc.

This news release contains "forward-looking statements" of Onyx within
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 2013  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that ... Marcum LLP Microcap Conference, May 30, in New ... Lyons , CPA, Chief Financial Officer of Cleveland BioLabs, ... 30 at 1:30 p.m. Eastern Time.  A live and archived ... Investors page of the Cleveland BioLabs website at www.cbiolabs.com ...
(Date:5/22/2013)... AudioNotch is the leading ... AudioNotch is pleased to announce a partnership with ... both British Columbia and Alberta, Destination Hearing is ... AudioNotch's tinnitus treatment program is now available at ... Hearing clinic, patients have the detection of their ...
(Date:5/22/2013)... NY (PRWEB) May 22, 2013 Mold remediation ... Products said that there is a way to cut down ... included on its latest post the details of a method ... much money. , Mold could be prevented, My Cleaning Products ... the company stated that a mold remediation must then be ...
(Date:5/22/2013)... 2013 Express Diagnostics Int’l, Inc. ... are pleased to announce a sponsorship agreement with ... New Zealand distributor of DrugCheck® onsite testing devices, manufactured ... in the Austin 400 May 17-19 in Austin, Texas. ... that involves each car of the Erebus Motorsport team ...
Breaking Biology Technology:Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2
... MichBio, the association for,Michigan,s life sciences industry, ... and Resources Guide, a complete listing of ... editorial pages with articles,on Michigan,s SmartZones, venture ... Universities Commercialization Initiative,and Core Technology Alliance, as ...
... Sept. 13 /PRNewswire-USNewswire/,-- To address the growing demand ... announced today the launch of its Center,for Biological ... by an,internationally recognized team of certified biosafety and ... range of specialized,laboratory consulting services from design, to ...
... Leaders,in Life Sciences and Clinical Diagnostics to Share ... 13 Luminex,Corporation (Nasdaq: LMNX ), the ... for Planet xMAP Europe 2007, the company,s,annual European ... 2-3 October at the Berlage,s Exchange in Amsterdam, ...
Cached Biology Technology:Midwest Research Institute Launches Center for Biological Safety and Security (CBS2) 2Luminex Corporation Hosts the Fifth Annual Planet xMAP Europe 2007 Symposium 2Luminex Corporation Hosts the Fifth Annual Planet xMAP Europe 2007 Symposium 3
(Date:5/21/2013)... concept of "place" is increasingly being considered in ... have a new resource that can help them ... with the places in their lives. , ... new book co-edited by the Pacific Northwest Research ... human-centered approach to conservation. The book is published ...
(Date:5/21/2013)... University researchers have developed a new method for ... holes in the cell surface. The technique could ... related biological fields. , Bulk electroporation a ... reversible nanopores in the cell membrane that are ... is an increasingly popular method of cell transfection. ...
(Date:5/21/2013)... at Chicago College of Medicine will study gender differences in ... energy source -- and how changes in fat metabolism play ... 4-year grant from the National Heart, Lung and Blood Institute. ... for energy. These changes may play a major role in ... and women, says E. Douglas Lewandowski, director of the UIC ...
Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2Do men's and women's hearts burn fuel differently? 2
... worm, a tiny soil-dwelling nematode worm but the implications ... a recent study authored by University of Nevada, Reno researcher ... of the Caenorhabditis elegans worm was published in ... "Circadian rhythms are important in all organisms because they regulate ...
... Research Council (BBSRC) at the University of Oxford have uncovered ... evidence of complex multicellular animal life appears around 550 million ... sharply from 3% to their modern day level of 21%. ... that humans share a method of sensing oxygen with the ...
... Sinai School of Medicine today announced that the National ... the National Institutes of Health (NIH), has renewed funding ... Experimentation (PRIME). This program seeks to develop easy-to-use, predictive ... individuals affected by the H1N1 and 1918 influenza viruses ...
Cached Biology News:Breakthrough in worm research has implications for human disease studies 2550 million years ago rise in oxygen drove evolution of animal life 2Consortium studying mathematical modeling of influenza infection 2